Correlation Between Neoleukin Therapeutics and Coherus BioSciences
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Coherus BioSciences, you can compare the effects of market volatilities on Neoleukin Therapeutics and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Coherus BioSciences.
Diversification Opportunities for Neoleukin Therapeutics and Coherus BioSciences
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neoleukin and Coherus is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Coherus BioSciences go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Coherus BioSciences
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to under-perform the Coherus BioSciences. But the stock apears to be less risky and, when comparing its historical volatility, Neoleukin Therapeutics is 1.69 times less risky than Coherus BioSciences. The stock trades about -0.1 of its potential returns per unit of risk. The Coherus BioSciences is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 814.00 in Coherus BioSciences on August 29, 2024 and sell it today you would lose (686.00) from holding Coherus BioSciences or give up 84.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 13.74% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Coherus BioSciences
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Coherus BioSciences |
Neoleukin Therapeutics and Coherus BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Coherus BioSciences
The main advantage of trading using opposite Neoleukin Therapeutics and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |